Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Baxter
Johnson and Johnson
Colorcon
Express Scripts

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 9,132,138

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,132,138
Title:Method for the treatment of multiple sclerosis
Abstract: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of 2ME2 or a derivative thereof.
Inventor(s): Mak; Tak Wah (Toronto, CA), Duncan; Gordon Stuart (Toronto, CA)
Assignee: CASI Pharmaceuticals, Inc. (Rockville, MD)
Application Number:13/789,849
Patent Claims:see list of patent claims

Details for Patent 9,132,138

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. RITUXAN rituximab Injection 103705 1997-11-26 ⤷  Try it Free 2039-02-26
Idec Pharmaceuticals Corp. RITUXAN rituximab Injection 103737 2002-02-19 ⤷  Try it Free 2039-02-26
Hoffmann-la Roche Inc. ZENAPAX daclizumab Injection 103749 1997-12-10 ⤷  Try it Free 2039-02-26
Biogen Inc. TYSABRI natalizumab Injection 125104 2004-11-23 ⤷  Try it Free 2039-02-26
Biogen Inc. ZINBRYTA daclizumab Injection 761029 2016-05-27 ⤷  Try it Free 2039-02-26
Biogen Inc. ZINBRYTA daclizumab Injection 761029 2017-05-26 ⤷  Try it Free 2039-02-26
Genentech, Inc. RITUXAN HYCELA rituximab and hyaluronidase human Injection 761064 2017-06-22 ⤷  Try it Free 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
Baxter
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.